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Key Points 
 
 WHO estimates up to 330 million people worldwide (4% of world population) have 
chronic ear infections with a significant proportion of these suffer from disabling 
hearing loss.  
 The majority of people with treatable ear diseases reside in low and middle-income 
countries where access to otoscopes is limited. 
 A novel, low-cost, LED-illuminated, solar-powered otoscope, the Arclight has been 
developed as a practical and economical alternative to traditional and more 
expensive devices. 
 In comparison to a traditional otoscope, the Arclight has been shown in our study to 
be equally effective in identifying common ear conditions.  
 By overcoming the barriers to acquisition and maintenance of a conventional 
otoscope in low resource settings, the Arclight has potential to assist in reduction of 
chronic ear diseases and the subsequent hearing loss in LMICs. 
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Background 
 
According to the World Health Organisation estimate, the global burden of illness from 
chronic ear infection affects about 4% of the world population (65 to 330 million) with ear 
discharge, 60% of whom (39 to 200 million) suffer from significant hearing impairment [1]. 
Alarmingly, over 90% of the burden of chronic ear infections is borne by low- and middle-
income countries (LMICs) [1].  
 
Although otitis media is largely preventable and treatable, over-stretched healthcare 
budgets in LMICs with minimal funding to equipment for clinics, either in the community or 
local hospitals, impose a significant barrier to the provision of basic ear and hearing care [2] 
[3].  In these low-resource settings, a traditional otoscope, essential for early diagnosis of 
common ear conditions, can be unrealistically expensive to acquire (with an average cost of 
£150) and impractical to maintain. With the lack of early recognition of ear infections with 
an appropriate device, treatment is unlikely to be effective with persistence of ear disease 
and its consequence of loss of hearing.  A lower cost, consumable independent alternative 
to the traditional otoscope would assist in the prevention and treatment of chronic ear 
infections, thus reducing the burden of needless disability in these regions.  
 
The ‘Arclight’ is a new, low cost solar-powered otoscope, that has been developed to meet 
the needs of health care workers in LMICs [4] [Figure 1]. A key patented design of the device 
is to employ a Light Emitting Diode (LED), which can be charged by an integrated 
photovoltaic (solar) panel. This eliminates the needs for expensive and bulky batteries and 
replacement filament bulbs. It is also slim and lightweight (110 mm long x 26 mm wide x 9 
mm thick, 18g), making it highly portable. In addition, the Arclight has an integrated 
magnifying loupe and can also function as an ophthalmoscope. Despite its multi-
functionality, when sold in bulk to users in LMICs, it can be purchased for around £10. 
As yet, however, there are no comparative studies published that evaluate the effectiveness 
of the Arclight compared to a traditional otoscope.  
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The aim of our study was, therefore, to assess the performance of the Arclight otoscope 
(AO), in comparison to a traditional otoscope (TO), in identifying common ear conditions by 
clinicians and to evaluate its ease-of-use. 
 
Methods 
21 clinicians were recruited from within the ear, nose and throat (ENT) departments of NHS 
Tayside and Fife. The participants included ENT consultants (7), ENT trainees (6), GP trainees 
(3), foundation year doctors (4) and a nurse practitioner (1). The TO used in this study was a 
WelchAllyn.  
Each participant assessed 14 different outer and middle ear simulation slides displayed in 
random order by an Oto-SIM© trainer. The simulations included commonly encountered 
outer and middle ear conditions such as a normal ear, wax impaction, foreign body in ear 
canal, exostoses, acute otitis externa, acute otitis media, tympanic membrane perforation, 
congenital and acquired choleasteatoma, tympanotomy tube, tympanosclerosis and a 
retraction pocket.  
Utilising a randomised cross-over strategy, 11 clinicians started with an AO to examine the 
simulations, before switching to a TO to repeat the assessment; while the remaining 10 
clinicians started with a TO before switching to an AO. The participants were asked to 
identify each simulation. Every correct answer received one mark with the time taken to 
reach an answer recorded by an independent assessor. The maximum score was therefore 
14 using either otoscope. The scores and time taken were normally distributed and a paired 
t-test was used to analyse the data.  
On completion of the study, each participant was asked to complete an 8 element 
questionnaire as listed below as well as an overall ease of use score.  
1. Ease of attachment of the speculum 
2. Stability of the speculum 
3. Ease of holding the otoscope 
4. Ease of insertion into the ear canal 
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5. Quality of view of the eardrum 
6. Brightness of the light 
7. Colour of light source 
8. Perceived build quality  
 
A 5-point Likert scale (1 - lowest score and 5 - highest score) was used to gain numerical 
feedback on each element. The Wilcoxon Signed rank test was used to analyse this non-
parametric paired data. 
 
Results 
 
Pathology identification 
Using the AO, clinicians achieved a mean score of 9.5 out of 14 compared to 10.0 with a TO 
(p = 0.39).  
Time taken to diagnosis 
The mean time taken to identification using the AO was 10.2 seconds and 9.1 seconds for 
the TO (p = 0.50).   
There was no statistically significant difference demonstrated between the two devices in 
either accuracy of diagnosis or the time taken to achieve a diagnosis.  
Feedback questionnaire 
The overall median feedback score was 4 for AO, compared to 5 for TO (p = 0.005). This 
difference was statistically significant. Among the items assessed, the qualities of view 
obtained, colour of the light source, speculum insertion and build of the AO were rated 
statistically lower by users compared to a TO. The feedback scores on the ease of 
attachment, ease of handling, stability, and brightness were however all similar with no 
statistical difference noted. [Figure 2] 
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Discussion 
Synopsis of key findings 
Early identification of ear diseases such as chronic suppurative otitis media relies upon 
recognition on otoscopy [5, 6] for a good outcome. Unfortunately, most medical devices 
including the TO are manufactured for high-income country (HIC) markets [7]. For users in 
LMICs, they tend to be impractically expensive to buy and often require costly and hard to 
source consumables, such as batteries and filament bulbs. If they break down, they are hard 
to fix and without regular maintenance, can become less effective. As a result, even if a 
health care worker in LMICs is donated a TO, like most other medical devices, after a period 
of intensive use, it is likely be found in a non-functional state in the ‘graveyard drawer’ [7] 
[8]. The AO overcomes the shortcomings associated with the TO being designed with the 
users in LMICs in mind but until this point, no evaluation of its performance to cost ratio, an 
essential factor for devices used in LMICs [9] had been performed. 
Our study has demonstrated that the objective diagnostic performance of the AO is non-
inferior to the TO in assisting clinicians to identify pathologies presented on a simulated 
outer and middle ear device. In addition, the users took the same period of time to make 
the diagnosis. The subjective scores by the clinicians however was that the AO scored lower 
for the quality of view obtained, the colour of the light source, the ease of speculum 
insertion and the build quality compared to the TO. 
Strengths and limitations; Comparisons with other studies 
The main strength of this study is that it is the first to make a comparative assessment of the 
AO and demonstrate its non-inferiority in performance against a TO.  Using a cross-over 
design adds weight to the validity of the findings. 
There are, however, a few limitations to this study. Firstly, a simulated ear, independent of 
its fidelity, can never replicate a real patient’s ear. Secondly, in order to reveal the true 
potential of the AO, it needs to be evaluated by its target users in a LMIC setting - ours was 
not. Thirdly, the diagnostic performance of the AO needs to be formally assessed against an 
agreed reference standard in a sufficiently powered study to assess the AO’s diagnostic 
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sensitivity and specificity potential. And lastly, as none of the users were exposed to an AO 
prior to the study, it is possible that the clinicians’ unfamiliarity with the new device and its 
perceived ‘cheapness’ introduced a negative bias, in particular as the assessment took place 
in specialist UK centres where a TO is always available as a ‘gold standard’ option. In view of 
the limitations, further assessments addressing these issues are recommended.  
As the Arclight is a new device, no preceding study has assessed its otoscope function. 
Nevertheless, its ophthalmoscope function has been evaluated. Blundell et al showed the 
Arclight ophthalmoscope to be as effective as the traditional direct ophthalmoscope at the 
hands of Malawian healthcare workers in diagnosing diabetic retinopathy in simulated eye 
study [10]. In addition, Lowe et al demonstrated the AO to be as effective as the traditional 
direct ophthalmoscope when assessing the optic nerve head cup to disc ratio in human eyes 
in Tanzania. This is important in the assessment of glaucoma [11]. Interestingly, in both of 
these two studies, the clinicians preferred the Arclight over the traditional device mainly 
because it was easier to use. 
Clinical applicability of the study 
This study is a stepping stone toward further evaluation of the Arclight as a practical low 
cost alternative to the TO. The Arclight, due to its multi-functionality, could prove an 
important device in empowering the healthcare workers to diagnose a range of not only ear, 
but also eye conditions in LMICs. With such a high performance to cost ratio and in an era of 
efficiency savings, the Arclight could also be used in the National Health Service (NHS) in the 
UK, even though the NHS clinicians are not the initial target end users.  
In conclusion, the AO is an effective and economical alternative to the TO. Moreover, 
preliminary studies demonstrate that the Arclight has the potential, not only to combat 
chronic ear infections and preventable hearing impairment in LMICs, but also an array of 
other conditions due to its versatility.  
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